Clinical trial NCT00418470 - References

Cystic Fibrosis — Prolonging the Duration of Peripheral Venous Catheters in Cystic Fibrosis People

Citation(s)

•   Alexander M (editor) Infusion Nursing Standard of Practice of the Intravenous Nurses Society
  Journal of Intravenous Nursing 2000; 23. 6S.
•   Ballarin S, Codamo T, Doro R, Loganes C, FESTINI F
  Pain in Italian Cystic Fibrosis adult patients: preliminary results of a national nurse led study. J of Cystic Fibrosis 2001; 1: 362.
•   Barker M, Thoenes D, Döhmen H, Friedrichs F, Pfannenstiel C, Heimann G
  Prevalence of thrombophilia and catheter-related thrombosis in cystic fibrosis. Pediatr Pulmonol. 2005 Feb;39(2):156-61.
•   Brandt CT
  [Phlebitis due to venous catheters. Causes and occurrence]. Ugeskr Laeger. 2000 Aug 21;162(34):4531-4. Danish.
•   Braun RP, Vecchietti JL, Thomas L, Prins C, French LE, Gewirtzman AJ, Saurat JH, Salomon D
  Telemedical wound care using a new generation of mobile telephones: a feasibility study. Arch Dermatol. 2005 Feb;141(2):254-8.
•   Breen L, Aswani N
  Elective versus symptomatic intravenous antibiotic therapy for cystic fibrosis. Cochrane Database Syst Rev. 2001;(4):CD002767. Review. Update in: Cochrane Database Syst Rev. 2012;7:CD002767.
•   Campbell WB, Elworthy S, Peerlinck I, Vanslembroek K, Bangur R, Stableforth D, Sheldon CD
  Sites of implantation for central venous access devices (ports): a study of the experiences and preferences of patients. Eur J Vasc Endovasc Surg. 2004 Dec;28(6):642-4.
•   Cystic Fibrosis Foundation
  Patient Registry 2004 Annual Report. Bethesda, Maryland
•   Deerojanawong J, Sawyer SM, Fink AM, Stokes KB, Robertson CF
  Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications. Thorax. 1998 Apr;53(4):285-9.
•   Duncan-Skingle F, Bramwell E
  Cystic Fibrosis Home care. In: Hodson ME, Geddes DM. Cystic Fibrosis. Arnold, London, 2000.
•   Esmond G, Butler M, McCormack AM
  Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis. J Clin Nurs. 2006 Jan;15(1):52-60.
•   Falchuk KH, Peterson L, McNeil BJ
  Microparticulate-induced phlebitis. Its prevention by in-line filtration. N Engl J Med. 1985 Jan 10;312(2):78-82.
•   Festini F, Ballarin S, Codamo T, Doro R, Loganes C
  Prevalence of pain in adults with cystic fibrosis. J Cyst Fibros. 2004 Mar;3(1):51-7.
•   FESTINI F, Beneventi R, Allegretti N, Vignoli N, Chiarelli F
  Does oral anti.inflammatory therapy influence the duration of peripheral venous catheters used for IV antibiotic cycles in cystic fibrosis patients ? Pediatr Pulmonol 2005; Suppl 28: 359-360.
•   Festini F, Beneventi R, Vignoli N, Allegretti N, Rontini I, Campigatto E, Grondoni G, Sanasi S, Bongini G
  [Factors that influence the duration of peripheral venous catheters used to antibiotic therapy in Cystic Fibrosis patients: results of a study]. Assist Inferm Ric. 2005 Apr-Jun;24(2):91-6. Italian.
•   FESTINI F, Bongini G, Vignoli N, Sanasi S, Campigatto E, Allegretti N, Rontini I, Grondoni G
  The number of daily IV administrations of antibiotics influences the duration of peripheral venous catheters in cystic fibrosis patients. Pediatr Pulmonol 2002; suppl 24:356.
•   Girón RM, Martínez A, Máiz L, Salcedo A, Beltrán B, Martínez MT, Antelo C, Barrio I, Prados C, Cabanillas J, Ancochea J
  [Home intravenous antibiotic treatments in cystic fibrosis units of Madrid]. Med Clin (Barc). 2004 May 8;122(17):648-52. Spanish.
•   Gronowitz E, Strandner K, Herlitz K et all
  A national Swedish survey of totally implantable venous access devices (TIVAD) in patients with Cystic Fibrosis (CF). J Cyst Fibros 2003;2:S72
•   Hessov I, Allen J, Arendt K, Gravholt L
  Infusion thrombophlebitis in a surgical department. Acta Chir Scand. 1977;143(3):151-4.
•   Hockenberry MJ
  Wong's clinical manual of pediatric nursing. Mosby 2004, St Louis, Missouri.
•   Jacobs WR, Zaroukian MH
  Coughing and central venous catheter dislodgement. JPEN J Parenter Enteral Nutr. 1991 Jul-Aug;15(4):491-3. Erratum in: JPEN J Parenter Enteral Nutr 1992 May-Jun;16(3):298.
•   Kerem E, Conway S, Elborn S, Heijerman H; Consensus Committee
  Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros. 2005 Mar;4(1):7-26. Review.
•   Lanbeck P, Odenholt I, Paulsen O
  Perception of risk factors for infusion phlebitis among Swedish nurses: a questionnaire study. J Infus Nurs. 2004 Jan-Feb;27(1):25-30.
•   Littlewood J, Bevan A, Commet G, Govan J
  Antibiotic treatment for cystic fibrosis. Cystic Fibrosis Trust 2002. Bromley, UK
•   Miall LS, Das A, Brownlee KG, Conway SP
  Peripherally inserted central catheters in children with cystic fibrosis. Eight cases of difficult removal. J Infus Nurs. 2001 Sep-Oct;24(5):297-300.
•   Millar-Jones L, Goodchild MC
  Peripheral long lines in cystic fibrosis. J Clin Pharm Ther. 1997 Feb;22(1):45-6.
•   Monreal M, Quilez F, Rey-Joly C, Rodriguez S, Sopena N, Neira C, Roca J
  Infusion phlebitis in patients with acute pneumonia: a prospective study. Chest. 1999 Jun;115(6):1576-80.
•   Munck A, Malbezin S, Bloch J, Gerardin M, Lebourgeois M, Derelle J, Bremont F, Sermet I, Munck MR, Navarro J
  Follow-up of 452 totally implantable vascular devices in cystic fibrosis patients. Eur Respir J. 2004 Mar;23(3):430-4.
•   Neri S, Allegretti N, Vignoli N, FESTINI F
  Perception of pain and fear related to invasive procedures in children with cystic fibrosis: a study using CF adults recalls. J Cyst Fibros 2006; 5 (suppl1): 91.
•   Proesmans M, Boulanger L, De Boeck K
  Complications with indwelling catheters in CF patients followed at the universital hospital in Leuven (Belgium). J Cyst Fibros 2002;S172-S173.
•   Regueiro Pose MA, Souto Rodríguez B, Iglesias Maroño M, Outón Fernández I, Cambeiro Nuñez J, Pértega Díaz S, Pita Fernández S
  [Peripheral venous catheters: incidence of phlebitis and its determining factors]. Rev Enferm. 2005 Oct;28(10):21-8. Spanish.
•   Richards C, Millar-Jones L, Alfaham M
  Assessment of in-line filters to prolong the life of intravenous cannulae in cystic fibrosis patients. J Clin Pharm Ther. 1995 Jun;20(3):165-6.
•   Riethmueller J, Busch A, Damm V, Ziebach R, Stern M
  Home and hospital antibiotic treatment prove similarly effective in cystic fibrosis. Infection. 2002 Dec;30(6):387-91.
•   Roberts GW, Holmes MD, Staugas RE, Day RA, Finlay CF, Pitcher A
  Peripheral intravenous line survival and phlebitis prevention in patients receiving intravenous antibiotics: heparin/hydrocortisone versus in-line filters. Ann Pharmacother. 1994 Jan;28(1):11-6.
•   Rodgers HC, Liddle K, Nixon SJ, Innes JA, Greening AP
  Totally implantable venous access devices in cystic fibrosis: complications and patients' opinions. Eur Respir J. 1998 Jul;12(1):217-20.
•   Salcedo A, Girón RM, Beltrán B, Martínez A, Máiz L, Suárez L; Fundación Sira Carrasco
  [Consensus conference: home intravenous antibiotic treatment for cystic fibrosis. The Sira Carrasco Foundation. 26 April 2002]. Arch Bronconeumol. 2003 Oct;39(10):469-75. Review. Spanish.
•   Strandvik B, Hjelte L, Malmborg AS, Widén B
  Home intravenous antibiotic treatment of patients with cystic fibrosis. Acta Paediatr. 1992 Apr;81(4):340-4.
•   Tager IB, Ginsberg MB, Ellis SE, Walsh NE, Dupont I, Simchen E, Faich GA
  An epidemiologic study of the risks associated with peripheral intravenous catheters. Am J Epidemiol. 1983 Dec;118(6):839-51.
•   The UK CF Nurse Specialist Group
  National consensus standards for the nursing management of cystic fibrosis. London, UK7 Cystic Fibrosis Trust; 2001.
•   Tolomeo C, Mackey W
  Peripherally inserted central catheters (PICCs) in the CF population: one center's experience. Pediatr Nurs. 2003 Sep-Oct;29(5):355-9.
•   Williams J, Smith HL, Woods CG, Weller PH
  Silastic catheters for antibiotics in cystic fibrosis. Arch Dis Child. 1988 Jun;63(6):658-9.

Prolonging the Duration on Site of Short Peripheral Venous Catheters Used to Administer Intravenous Antibiotics in Cystic Fibrosis Adults. Randomized Controlled Trial on the Effect of Different Concentrations of Antibiotic in Normal Saline

Details for clinical trial NCT00418470